iRay Technology Hits Day Low at CNY 184.67 Amid Price Pressure

iRay Technology Co., Ltd. experienced a significant decline in its stock performance on June 1, 2026, with a drop of 7.98%. The stock reached an intraday low of CNY 184.67, reflecting a challenging day for the company within the Pharmaceuticals & Biotechnology sector. Despite this downturn, iRay Technology has shown notable performance metrics over various time frames. Over the past year, the stock has generated a return of 58.59%, outperforming the China Shanghai Composite, which recorded a return of 21.22%. Year-to-date, iRay has achieved an impressive 83.85% return, indicating strong performance relative to the broader market. However, the company faces some financial pressures, including a decline in profits by 27.8% over the past year, despite its stock price appreciation. The company has also reported negative results for the last three consecutive quarters, and its dividend payout ratio remains at 0%. With a market capitalization of CNY 28,291 million, iRay Technology continues to navigate a complex financial landscape, marked by high valuation metrics such as a Price to Book ratio of 4.37 and a P/E ratio of 37.00.